Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1059 | 911 | 1059 | 1057 | 1276 | 1715 |
Fund Return | 5.94% | -8.94% | 5.94% | 1.86% | 5% | 5.54% |
Place in category | 125 | 376 | 125 | 196 | 423 | 133 |
% in Category | 5 | 17 | 5 | 10 | 28 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GS India Equity Portfolio Base Acc | 4.81B | 20.02 | 7.94 | 10.27 | ||
GS India Equity Portfolio Base Inc | 4.81B | 20.02 | 7.94 | 10.28 | ||
GS India Equity Portfolio I A Inc | 4.81B | 19.41 | 7.40 | 9.72 | ||
GS India Equity Portfolio I Acc | 4.81B | 21.21 | 9.00 | 11.41 | ||
Goldman Sachs India Equity Portfoli | 4.81B | 20.66 | 8.50 | 10.91 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund N1 USD | 2.46B | 1.25 | -1.50 | 4.92 | ||
MFSM European Value Fund W1 USD | 2.28B | -0.87 | -3.20 | 6.18 | ||
MFSM European Value Fund A1 USD | 2.34B | -1.61 | -3.92 | 5.39 | ||
MFSM European Value Fund I1 USD | 2.34B | -0.81 | -3.03 | 6.42 | ||
JPEurope Equity Plus Fund C perf ac | 2.27B | 12.05 | 7.38 | 6.12 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eurx/Eurx Er Stx 50 12/2024 | DE000C6XKBY2 | 8.16 | - | - | |
Novo Nordisk B | DK0062498333 | 3.93 | 575.6 | -4.34% | |
SAP | DE0007164600 | 3.28 | 256.850 | +0.71% | |
Novartis | CH0012005267 | 2.66 | 89.32 | -1.40% | |
Life/New Ftse 100 12/2024 | GB00KKY7ZY67 | 2.42 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review